Back to GetFilings.com



Table of Contents



SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

(Mark One)

x     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 28, 2003
or

o     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to

Commission file number: 0-27892

SIPEX Corporation
(Exact Name of Registrant as Specified in its Charter)

     
Massachusetts
(State or Other Jurisdiction of
Incorporation or Organization)
  04-6135748
(I.R.S. Employer
Identification No.)
     
233 South Hillview Drive, Milpitas, California
(Address of principal executive offices)
  95035
(Zip Code)

(408) 934-7500
Registrant’s telephone number, including area code


Former name, former address and former fiscal year if changed since last report.

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes x No o

There were 28,110,311 shares of the Registrant’s Common Stock issued and outstanding as of August 5, 2003.



 


TABLE OF CONTENTS

Part I: FINANCIAL INFORMATION
Item 1: Financial Statements
Consolidated Balance Sheets at June 28, 2003 and December 31, 2002
Consolidated Statements of Operations for the three and six months ended June 28, 2003 and June 29, 2002
Consolidated Statements of Cash Flows for the six months ended June 28, 2003 and June 29, 2002
Notes To Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosure about Market Risk
Item 4. Controls and Procedures
PART II: OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Submission of Matters to a Vote of Security Holders
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
EXHIBIT 10.30
EXHIBIT 10.31
EXHIBIT 10.32
EXHIBIT 10.33
EXHIBIT 10.34
EXHIBIT 99.1
EXHIBIT 99.2


Table of Contents

FORM 10-Q
SIX MONTHS ENDED JUNE 28, 2003

INDEX

                 
Item                
Number           Page  

         
 
PART I:
  FINANCIAL INFORMATION        
Item 1
  Financial Statements        
 
  Consolidated Balance Sheets at June 28, 2003 and December 31, 2002     3  
 
  Consolidated Statements of Operations for the three and six months ended June 28,     4  
 
  2003 and June 29, 2002        
 
  Consolidated Statements of Cash Flows for the six months ended June 28, 2003 and     5  
 
  June 29, 2002        
 
  Notes To Consolidated Financial Statements     7  
Item 2
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     12  
Item 3
  Quantitative and Qualitative Disclosure about Market Risk     25  
Item 4
  Controls and Procedures     25  
PART II:
  OTHER INFORMATION        
Item 1
  Legal Proceedings     26  
Item 2
  Changes in Securities and Use of Proceeds     26  
Item 3
  Defaults Upon Senior Securities     27  
Item 4
  Submission of Matters to a Vote of Security Holders     27  
Item 5
  Other Information     27  
Item 6
  Exhibits and Reports on Form 8-K     27  
 
  SIGNATURES     29  

2


Table of Contents

Part I: FINANCIAL INFORMATION

Item 1: Financial Statements

SIPEX CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
(Unaudited)

                     
        June 28, 2003     December 31, 2002  
       
   
 
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 18,644     $ 6,489  
 
Short-term investment securities
    1,499       9,980  
 
Accounts receivable, less allowances of $511 and $945 at June 28, 2003 and December 31, 2002, respectively
    9,357       7,278  
 
Inventories
    13,373       14,393  
 
Prepaid expenses and other current assets
    2,550       3,446  
 
 
   
 
   
Total current assets
    45,423       41,586  
Property, plant, and equipment, net
    53,469       56,997  
Other assets
    462       203  
 
 
   
 
   
Total assets
  $ 99,354     $ 98,786  
 
 
   
 
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
Current liabilities:
               
 
Accounts payable
  $ 8,427     $ 8,103  
 
Accrued expenses
    4,224       3,570  
 
Accrued restructuring costs
    79       755  
 
Deferred income
    2,513       1,383  
 
 
   
 
   
Total current liabilities
    15,243       13,811  
Long-term debt
    21,168       10,455  
 
 
   
 
   
Total liabilities
    36,411       24,266  
 
 
   
 
Contingencies
           
Shareholders’ equity:
               
 
Preferred stock, $0.01 par value, 1,000 shares authorized and no shares issued or outstanding
           
 
Common stock, $0.01 par value, 60,000 shares authorized and 28,101 shares issued and outstanding at June 28, 2003 and December 31, 2002, respectively
    281       280  
 
Additional paid-in capital
    175,727       175,489  
 
Accumulated deficit
    (113,038 )     (101,179 )
 
Accumulated other comprehensive loss
    (27 )     (70 )
 
 
   
 
   
Total shareholders’ equity
    62,943       74,520  
 
 
   
 
   
Total liabilities and shareholders’ equity
  $ 99,354     $ 98,786  
 
 
   
 

See accompanying notes to consolidated financial statements

3


Table of Contents

SIPEX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)

                                     
        Three Months Ended     Six Months Ended  
       
   
 
        June 28, 2003     June 29, 2002     June 28, 2003     June 29, 2002  
       
   
   
   
 
Net sales
  $ 14,891     $ 16,988     $ 30,008     $ 33,052  
Cost of sales
    12,496       19,231       27,795       33,420  
 
 
   
   
   
 
 
Gross profit (loss)
    2,395       (2,243 )     2,213       (368 )
 
 
   
   
   
 
Operating expenses:
                               
 
Research and development
    3,427       3,560       6,360       6,274  
 
Marketing and selling
    1,444       2,206       3,368       4,472  
 
General and administrative
    2,146       2,645       4,115       4,300  
 
Restructuring and facility exit costs
    (294 )           (300 )      
 
Impairment of goodwill
          2,984             2,984  
 
 
   
   
   
 
   
Total operating expenses
    6,723       11,395       13,543       18,030  
 
 
   
   
   
 
Loss from operations
    (4,328 )     (13,638 )     (11,330 )     (18,398 )
Other expense, net
    (226 )     (29 )     (265 )     (116 )
 
 
   
   
   
 
Loss before income taxes
    (4,554 )     (13,667 )     (11,595 )     (18,514 )
Income tax expense
    83       33,826       264       31,936  
 
 
   
   
   
 
Net loss
  $ (4,637 )   $ (47,493 )   $ (11,859 )   $ (50,450 )
 
 
   
   
   
 
Net loss per common share — basic and diluted
  $ (0.17 )   $ (1.70 )   $ (0.42 )   $ (1.91 )
 
 
   
   
   
 
Weighted average common shares outstanding — basic and diluted
    28,055       27,930       28,043       26,402  
 
 
   
   
   
 

See accompanying notes to consolidated financial statements

4


Table of Contents

SIPEX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)

                         
            Six Months Ended  
           
 
            June 28, 2003     June 29, 2002  
           
   
 
Operating activities:
               
 
Net loss
  $ (11,859 )   $ (50,450 )
 
Adjustments to reconcile net loss to net cash used in operating activities:
               
   
Deferred income taxes
          31,851  
   
Provision for uncollectible receivables and returns and allowances
    (435 )     713  
   
Fixed asset impairment loss
    238        
   
Amortization of debt issue costs
    4        
   
Stock compensation expense
    55        
   
Loss on fixed asset disposition
    196        
   
Depreciation and amortization
    3,790       4,219  
   
Impairment of goodwill
          2,984  
   
Write down of excess and obsolete inventories
    318        
   
Amortization of discount on long-term debt
    154        
   
Amortization of discount on short-term investment securities
    (27 )      
   
Changes in current assets and liabilities:
               
     
Accounts receivable
    (1,644 )     (1,699 )
     
Inventories
    702       (396 )
     
Prepaid expenses and other current assets
    896       (31 )
     
Other assets
    (136 )      
     
Accounts payable
    324       4,389  
     
Accrued expenses
    654       1,202  
     
Accrued restructuring costs
    (676 )      
     
Deferred income
    1,130       (173 )
 
 
   
 
       
Net cash used in operating activities
    (6,316 )     (7,391 )
 
 
   
 
Investing activities:
               
 
Purchase of short-term investment securities
    (1,492 )     (5,961 )
 
Proceeds from maturity of short-term investment securities
    10,000        
 
Purchase of property, plant and equipment
    (696 )     (2,870 )
 
 
   
 
       
Net cash provided by (used in) investing activities
    7,812       (8,831 )
 
 
   
 
Financing activities:
               
 
Debt issuance costs
    (128 )      
 
Proceeds from issuance of common stock
    184       24,226  
 
Proceeds from issuance of convertible secured note
    10,560          
 
Payments of debt obligations
          (7,396 )
 
 
   
 
       
Net cash provided by financing activities
    10,616       16,830  
 
 
   
 
Effect of foreign currency exchange rate changes on cash and cash equivalents
    43       (56 )
 
 
   
 
Increase in cash and cash equivalents
    12,155       552  
Cash and cash equivalents, beginning of period
    6,489       4,874  
 
 
   
 
Cash and cash equivalents, end of period
  $ 18,644     $ 5,426  
 
 
   
 

5


Table of Contents

                         
            Six Months Ended  
           
 
            June 28, 2003     June 29, 2002  
           
   
 
Supplemental cash flow information:
               
 
Cash paid during the period for:
               
   
Income taxes
  $     $ 81  
   
Interest
  $ 170     $ 12  

See accompanying notes to consolidated financial statements

6


Table of Contents

SIPEX CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

Note 1 — Basis of Presentation

Unaudited Interim Financial Information

     We have prepared the accompanying consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. As used herein, “Sipex,” the “Company,” “we,” “our” and similar terms include Sipex Corporation and its wholly-owned subsidiaries, unless the context indicates otherwise. These consolidated financial statements are unaudited and, in our opinion, include all adjustments, consisting of normal recurring adjustments and accruals necessary for a fair presentation of the consolidated balance sheets, operating results and cash flows for the periods presented. Operating results for the three and six months ended June 28, 2003 are not necessarily indicative of the results that may be expected for the year ending December 31, 2003 due to cyclical and other factors. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States have been omitted in accordance with the rules and regulations of the SEC. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended December 31, 2002. Certain prior period amounts have been reclassified to conform to the current period presentation. Such reclassifications had no effect on net loss as previously reported.

Principles of Consolidation

     The consolidated financial statements include the accounts of Sipex and all of its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Note 2 — Effect of Recent Accounting Pronouncements

     In April 2002, the FASB issued SFAS No. 145, “Rescission of FASB Statements 4, 44, and 64, Amendment of FASB Statement No. 13 and Technical Corrections,” effective for fiscal years beginning May 15, 2002 or later. It rescinds SFAS No. 4, “Reporting Gains and Losses From Extinguishments of Debt,” SFAS No. 64, “Extinguishments of Debt to Satisfy Sinking-Fund Requirements,” and SFAS No. 44, “Accounting for Intangible Assets of Motor Carriers.” This Statement also amends SFAS No. 13, “Accounting for Leases,” to eliminate an inconsistency between the required accounting for sale-leaseback transactions and the required accounting for certain lease modifications that have economic effects similar to sale-leaseback transactions. This Statement also amends other existing authoritative pronouncements to make various technical corrections, clarify meanings or describe their applicability under changed conditions. On January 1, 2003, the Company adopted SFAS No. 145 with no material impact on its financial position, results of operations or cash flows.

     In June 2002, the FASB issued SFAS No. 146, “Accounting for Costs Associated With Exit or Disposal Activities.” SFAS No. 146 requires companies to recognize costs associated with exit or disposal activities when they are incurred rather than at the date of commitment to an exit or disposal plan. This Statement is effective for exit or disposal activities initiated after December 31, 2002. On January 1, 2003, the Company adopted SFAS No. 146 and there was no material impact on its financial position or results of operations. Management does not expect that SFAS 146 will have a significant impact to the Company’s financial position, results of operations or cash flows.

     In November 2002, the FASB issued FASB Interpretation No. 45 (“FIN 45”), “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others”. FIN 45 requires that upon issuance of a guarantee, a guarantor must recognize a liability for the fair value of a stand-ready to perform obligation assumed under a guarantee. Additionally, a guarantor must recognize a contingent obligation to make future payments when such obligation becomes probable and estimable. FIN 45 also requires additional disclosures by a guarantor in its interim and annual financial statements about the obligations associated with

7


Table of Contents

guarantees issued. The recognition provisions of FIN 45 are effective for any guarantees that are issued or modified after December 31, 2002. The Company does not guarantee any obligations. The adoption of this interpretation did not have a material impact on the Company’s financial statements.

Note 3 — Stock-Based Compensation

     In December 2002, the FASB issued SFAS No. 148, “Accounting for Stock-Based Compensation — Transition and Disclosure — an Amendment of SFAS 123.” SFAS No. 148 provides additional transition guidance for those entities that elect to voluntarily adopt the provisions of SFAS No. 123, “Accounting for Stock-Based Compensation.” Furthermore, SFAS No. 148 mandates prominent disclosures in both interim and year-end financial statements about the fair value based method of accounting for stock-based employee compensation and the effect of the method used on reported results. SFAS No. 148 is effective for fiscal years ending after December 15, 2002. The adoption of SFAS No. 148 did not have a material effect on the Company’s financial position or results of operations as the Company does not intend to adopt the fair value method of accounting for stock-based employee compensation.

     The Company accounts for its stock-based employee compensation plans under the recognition and measurement principles of APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations. No stock based compensation cost is reflected in net loss, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net loss and net loss per share as if the Company had applied the fair value recognition provisions of FASB Statement No. 123, “Accounting for Stock Based Compensation,” as amended by SFAS No. 148, to stock-based employee compensation in each period: (in thousands, except per share data)

                                   
      3 Months Ended     6 Months Ended  
     
   
 
      June 28, 2003     June 29, 2002     June 28, 2003     June 29, 2002  
     
   
   
   
 
Net loss
  $ 4,637     $ 47,493     $ 11,859     $ 50,450  
Less: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects
    4,274       3,582       8,577       6,011  
 
   
     
     
     
 
Pro forma net loss
    8,911       51,075       20,436       56,461  
 
   
     
     
     
 
Net loss per share:
                               
 
Basic and diluted — as reported
  $ (0.17 )   $ (1.70 )   $ (0.42 )   $ (1.91 )
 
Basic and diluted — proforma
  $ (0.32 )   $ (1.83 )   $ (0.73 )   $ (2.14 )

The fair value for each award granted was estimated at the date of grant using the Black-Scholes option-pricing model, assuming no expected dividends and the following weighted average assumptions:

                                 
    3 Months Ended     6 Months Ended  
   
   
 
    June 28, 2003     June 29, 2002     June 28, 2003     June 29, 2002  
   
   
   
   
 
Average risk-free interest rates
    2.1 %     4.0 %     2.3 %     4.0 %
Average expected life (in years)
    4.0       6.0       4.0       6.0  
Volatility
    200 %     247 %     200 %     247 %

Note 4 — Net Loss Per Share

     Basic net loss per share is based upon the weighted average number of common shares outstanding. Diluted net loss per share is based upon the weighted average number of common and common equivalent shares outstanding assuming dilution. Common equivalent shares, consisting of outstanding stock options and warrants, are included in the per share calculations where the effect of their inclusion would be dilutive. As the Company is in a net loss position, the weighted average number of common and common equivalent shares outstanding equals the weighted average number of common and common equivalent shares assuming dilution. Antidilutive potential common shares excluded from the dilution calculation represent 8,949,000 and 5,116,000 potential common shares for the three months ended June 28, 2003 and June 29, 2002, respectively, and 8,959,000 and 5,204,000 potential common shares for the six months ended June 28, 2003 and June 29, 2002, respectively.

8